Search clinical trials for: Alisartan, Amlodipine besylate

Total 2864 results

Ahn-Gook Pharmaceuticals Co.,Ltd
Asan Medical Center

Completed

Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301

Hypertension

Korea, Republic of
Dong-A Pharmaceutical Co., Ltd.

Completed

A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male Volunteers

Healthy Male Volunteer
Columbia University

Completed

N-of-1 Trials for Blood Pressure Medications in Adults

Hypertension | High Blood Pressure

United States
Hospital Israelita Albert Einstein
Libbs Farmacêutica LTDA

Recruiting

Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial Hypertension (OPTION TREAT)

Hypertension

Brazil
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk (TOGETHER)

Hypertension | Dyslipidemia

United States
Hanmi Pharmaceutical Company Limited

Completed

A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Hypertension

Korea, Republic of
Assaf-Harofeh Medical Center

Unknown

Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?

Hypertension
GlaxoSmithKline

Completed

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers

Hypertension

Australia
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) Conditions

Healthy
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting Conditions

Healthy
Shanghai Haini Pharmaceutical Co., Ltd.

Completed

Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy Volunteers

Bioequivalence

China
Brigham and Women's Hospital

Active, not recruiting

Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty

Frailty | Heart Failure, Systolic

United States
Takeda

Completed

Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension

Essential Hypertension

China
HK inno.N Corporation

Completed

Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

Hypertension With Hyperlipidemia
Eisai Limited

Completed

An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Liposomal Formulation in Patients With Solid Tumors

Solid Tumors

United Kingdom
Saitama Medical University

Completed

Effects of Angiotensin Receptor Antagonist on Prohibiting Cardiovascular Events on Hemodialysis Patients

Cardiovascular Disease
Novartis Pharmaceuticals

Completed

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Hypertension

Czech Republic, Finland, France, Germany, Hungary, Italy, Poland, Slovakia, Spain, Sweden
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan Alone

Hypertension

Switzerland, Germany
Novartis

Completed

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Hypertension

Switzerland, Germany
Novartis

Completed

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

Primary Hypertension

Egypt
Novartis

Completed

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension

Hypertension

United States
University of Michigan

Withdrawn

Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis

Hemodialysis | Pharmacokinetics

United States
University of Texas Southwestern Medical Center
National Center for Advancing Translational Sciences (NCATS)

Completed

Pharmacokinetics of Amlodipine Besylate at Delivery and During Lactation

Chronic Hypertension in Pregnancy

United States
InVasc Therapeutics, Inc.

Unknown

Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome (AMORE)

Hypertension

United States
Taipei Veterans General Hospital, Taiwan

Completed

The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)

Ischemic Stroke
Torrent Pharmaceuticals Limited

Completed

Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult Subjects

Healthy

United States
Novartis

Completed

A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

HYPERTENSION

Switzerland, Germany
Novartis

Completed

One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With Hypertension

Hypertension

United States, Germany
Takeda

Completed

Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.

Grade I or II Essential Hypertension

Japan
Torrent Pharmaceuticals Limited

Completed

Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 18 Fed, Healthy Adult Subjects

Healthy

United States
University of Iowa
Fabtech Systems

Not yet recruiting

The Effects of Heel Distraction Height on Foot Loading With Carbon Fiber Custom Dynamic Orthoses (CDODistract)

Traumatic Lower Limb Injury
University of Iowa

Recruiting

Reliability of Force Measurement Within the Carbon Fiber Orthosis Proximal Cuff (CuffForce)

Healthy

United States
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension

Hypertension

Germany, Switzerland, United Kingdom
Korea University Anam Hospital
Hanmi Pharmaceutical co., ltd.

Completed

The Pharmacokinetic Interaction Between Amlodipine and Losartan

Healthy

Korea, Republic of
Ullevaal University Hospital
Merck Sharp & Dohme LLC

Completed

Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)

Hypertension

Norway
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine Alone

Hypertension

Switzerland, Germany
PharmEvo Pvt Ltd

Completed

Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial (ALERT)

Essential Hypertension

Pakistan
Novartis

Completed

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

Hypertension

United States
Novartis

Completed

Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Hypertension

Switzerland, Germany
LG Life Sciences

Unknown

Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

Orthostatic Hypertension | Lower Leg Edema

Korea, Republic of
Novartis Pharmaceuticals

Completed

The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

Hypertension | Diastolic Dysfunction

United States
Centro Universitario de Ciencias de la Salud, Mexico

Unknown

Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With Hypertension

Arterial Hypertension
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension

Essential Hypertension

China
Teva Pharmaceuticals USA

Completed

Amlodipine 10 mg Tablets Under Fed Conditions

Healthy

Canada
Novartis

Completed

Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension

Essential Hypertension
Brillian Pharma Inc.
Accutest Research Laboratories (I) Pvt. Ltd.

Completed

Amlodipine Freeze-Dried Powder for Oral Solution 5 mg

Coronary Artery Disease | Hypertension

India
Ahn-Gook Pharmaceuticals Co.,Ltd

Unknown

Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension

Hypertension
Novartis

Completed

Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus Felodipine

Hypertension

Germany
Chong Kun Dang Pharmaceutical
Severance Hospital

Completed

Drug-drug Interaction Study(CKD-501, Amlodipine)

Type 2 Diabetes Mellitus

Korea, Republic of
Nara Medical University

Completed

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering (NARA)

Hypertension

Japan

3

Subscribe